Views & Analysis The future of the clinical trial – collaboration and patient... Greater patient centricity, collaboration and new technology are re-shaping clinical trials.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
Articles Meeting the needs of cancer patients and healthcare provider... Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
Views & Analysis Patient-led trials: a formula for success The benefits and pitfalls of patient-centric and patient-led trials.
Views & Analysis Health literacy: help pharma communicate with patients Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
Views & Analysis Dynamic consent models can benefit clinical trials Dynamic consent models for patients can develop ongoing partnership between participants and researchers.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.